Abstract
Neuropsychological testing (NPT) needs to be reserved for patients requiring particularly detailed testing when the symptoms are covert and subtle or where deficits need more precise cognitive appraisal. This applies especially to those with subjective complaints (so- called “worried well”), where close monitoring of cognitive deficits over time is required as with rehabilitation interventions or studies and medicolegal-related assessments. NPT is constrained principally by testing duration and availability. It should also be noted that acute and subacute neurological patients in a tertiary medical setting are often not amenable to NPT as they have obvious significant impairments such as delirium, encephalopathy, global aphasia, severe neglect syndromes or anosognosias, and many common stroke syndromes. In dementia, basic screening is possible, but with mild cognitive impairment, NPT is often indicated. Multiple sclerosis is a good example where elementary neurological deficits such as ophthalmoparesis, ataxia, and sensorimotor impairments may overshadow the majority of patients who have altered cognitive as well as behavioral deficits. Neurotoxicological exposure manifests with executive dysfunction and malingering are very good examples of where NPT may play a pivotal role in diagnosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ferguson JH, Altrocchi P, Brin M, et al. Assessment: neuropsychological testing of adults: considerations for neurologists. Report of the therapeutics and technology assessment Subcommittee of the American Academy of neurology. Neurology. 1996;47:592–9.
Tangalos EG, Smith GE, Ivnik RJ, et al. The mini-mental state examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc. 1996;71:829–37.
Ana-Claire L, Meyer ACL, Boscardin WJ, Kwasa JK, et al. Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power. Neuroepidemiology. 2013;41:208–16. https://doi.org/10.1159/000354629.
Lewis MS, Maruff P, Silbert BS, et al. Detection of postoperative cognitive decline after coronary artery bypass graft surgery is affected by the number of neuropsychological tests in the assessment battery. Ann Thoracic Sug. 2006;81(6):2097–104.
Cooney L, Balcezak T. Cognitive testing of older clinicians prior to recredentialing. JAMA. 2020;323:179–80.
Armstrong KA, Reynolds EE. Opportunities and challenges in valuing and evaluating aging physicians. JAMA. 2020;323:125–6.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hoffmann, M. (2020). Neuropsychological and Computerized Testing. In: Clinical Mentation Evaluation. Springer, Cham. https://doi.org/10.1007/978-3-030-46324-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-46324-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-46323-6
Online ISBN: 978-3-030-46324-3
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)